CAS 852155-81-8

Formule : C20H31N7O9

InChI : InChI=1S/C20H31N7O9/c1-9(25-18(33)12(21)5-11-6-22-8-24-11)17(32)26-13(3-4-15(30)31)19(34)23-7-14(29)27-16(10(2)28)20(35)36/h6,8-10,12-13,16,28H,3-5,7,21H2,1-2H3,(H,22,24)(H,23,34)(H,25,33)(H,26,32)(H,27,29)(H,30,31)(H,35,36)/t9-,10+,12-,13-,16-/m0/s1

Code InChI : LUWRDKLVTXFZFK-AWCHJOLGSA-N

SMILES : C[C@H]([C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CN=CN1)N)O

HAEGT

CAS : 852155-81-8

HAEGT

Formule : C₂₀H₃₁N₇O₉

Degré de pureté : 98%

Masse moléculaire : 513.5

Ref: 54-OR1134048

HAEGT

CAS : 852155-81-8

HAEGT is the first N-terminal 1-5 residues of GLP-1 peptide.

Formule : C₂₀H₃₁N₇O₉

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 513.5016

Ref: TM-TP1381

HAEGT

CAS : 852155-81-8

Formule : C₂₀H₃₁N₇O₉

Degré de pureté : 98%

Masse moléculaire : 513.5016

Ref: IN-DA01EO3K

(4S)-4-[(2S)-2-[(2S)-2-Amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl)c arbamoyl]butanoic acid

CAS : 852155-81-8

(4S)-4-[(2S)-2-[(2S)-2-Amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl) c arbamoyl]butanoic acid is a glp-1 analogue that may be used for the treatment of metabolic disorders. It has been shown to increase insulin production in response to glucose and also has site specific activity. The compound binds to insulin receptors, which leads to increased synthesis of intracellular insulin and activation of downstream signaling pathways. The analog has a neutral pH and is stable in biological fluids such as human serum or dogfish plasma.

Formule : C₂₀H₃₁N₇O₉

Degré de pureté : Min. 95%

Masse moléculaire : 513.5 g/mol

Ref: 3D-CJB15581